Teclistamab-Daratumumab in AL Amyloidosis

Clinical trial NCT07110844 · RECRUITING

Trial details

NCT number: NCT07110844
Sponsor: Rajshekhar Chakraborty, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Amyloid Light-chain Amyloidosis

Start date: 2025-11-07
Primary completion: 2031-10-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.